Sorafenib and RAD001 Renal Cell Carcinoma
NCT00384969
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Renal Cell Carcinoma
Interventions
DRUG:
RAD001 and Sorafenib
Sponsor
University of California, San Francisco
Collaborators
[object Object]